A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 58
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LA
Long Form : Linear Array
No. Year Title Co-occurring Abbreviation
2018 Evaluation of a Novel Single-Tube Method for Extended Genotyping of Human Papillomavirus. HC2, HPV, HR-HPV
2018 Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing. HC2, HPV
2017 Genotyping of high-risk anal human papillomavirus (HPV): ion torrent-next generation sequencing vs. linear array. HPV, NGS, PPV
2017 Universal Human Papillomavirus Typing Assay: Whole-Genome Sequencing following Target Enrichment. eWGS, HPV
2016 Comparison of DNA testing strategies in monitoring human papillomavirus infection prevalence through simulation. HC2, PCR
2016 Evaluating HPV-negative CIN2+ in the ATHENA trial. ---
2015 Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study. CIN, HC2, HPV
2015 Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples. GA, HPV
2015 Development of a novel liquid bead array human papillomavirus genotyping assay (PGMY-LX) and comparison with linear array for continuity in longitudinal cohort studies. HPV
10  2015 Human papillomavirus genotyping by Linear Array and Next-Generation Sequencing in cervical samples from Western Mexico. HPV, NGS
11  2015 The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia. CI, HC2, HPV, HR, RLB
12  2013 Can clinical tests help monitor human papillomavirus vaccine impact? CIs, HC2, HPV
13  2013 Genital human papillomaviruses among women of reproductive age in Jamaica. HPV
14  2013 HPV Direct Flow CHIP: a new human papillomavirus genotyping method based on direct PCR from crude-cell extracts. HC2, HPV
15  2013 Male circumcision reduces penile high-risk human papillomavirus viral load in a randomised clinical trial in Rakai, Uganda. HR-HPV
16  2013 Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada. BC, HR
17  2013 Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy. HPV, HR-HPV, LR-HPV
18  2012 A real-time PCR assay for HPV52 detection and viral load quantification. HPV
19  2012 Clinical performance assessment of five human papillomavirus DNA tests using liquid-based cytology samples. CIN, HR, PCR
20  2012 Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance. ASCUS, HCII, HPV, HR
21  2012 Comparison of PapType to Digene Hybrid Capture 2, Roche linear array, and Amplicor for detection of high-risk human papillomavirus genotypes in women with previous abnormal pap smears. Amp, HC2, HPV
22  2012 Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples. HPV
23  2012 Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests. FDA, HC2, HPV, PaP Cohort
24  2012 Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population. ASCUS, HC2, HPV, HR-HPV, LSIL
25  2012 Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium. ASCUS, HR-HPV, LSIL
26  2012 Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer. HC2, HR-HPV, LBA
27  2012 Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. AUC, CIN2, HPV, qPCR, ROC
28  2012 Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation. HC2, HPV, HR, LR, NCSP, POPI
29  2011 Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer. CI, HC2, HPV
30  2011 Comparative performance of human papillomavirus DNA testing using novel sample collection methods. HC2, HPV
31  2011 Comparison of 2 line blot assays for defining HPV genotypes in oral and oropharyngeal squamous cell carcinomas. HPV, LiPA
32  2011 Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix. ASCUS, CI, HC2, HPV, HR-HPV
33  2011 Impact of HPV assay on observed population prevalence. HPV, PLB
34  2011 Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array. HPVs
35  2010 Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay. HCII
36  2010 Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay. GA, HPV, HPV16
37  2010 Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection. HCII, HR, PCR, RT
38  2010 Human papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays. HPV
39  2010 Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection. HC2, HR-HPV
40  2010 Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay. HCII, HPV, HR
41  2009 Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. HC2, HPV, HR, LR
42  2009 Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland. HR
43  2009 Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology. ASCUS, HC2, HR, LBC
44  2009 Comparison of human papillomavirus detection and typing by hybrid capture 2, linear array, DNA chip, and cycle sequencing in cervical swab samples. HCII, HPVs
45  2009 Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test. ---
46  2008 A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. ASCUS, CIN, HPV
47  2008 Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. ASCUS, HPV, LBA
48  2008 Comparison of two PCR-based human papillomavirus genotyping methods. HPV
49  2008 Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests. CIN2, HCII, HPV
50  2008 Evaluation of different techniques for identification of human papillomavirus types of low prevalence. HPVs, LiPA, RLB
51  2008 Human papillomavirus genotype specificity of hybrid capture 2. ASCUS, HC2, HPV, HPV35, LBA
52  2008 Time-resolved step-scan infrared imaging system utilizing a linear array detector. FTIR, IR, LC
53  2007 Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples. HC2, HPV, HR
54  2007 Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. AMP, HC2, HPV, HR
55  2007 Roche AMPLICOR human papilloma virus (HPV) and LINEAR ARRAY HPV tests will profit from automated DNA extraction. HPV, HR-HPV, MP-LC
56  2007 The effect of different DNA isolation methods on the outcome of high-risk HPV testing. HR-HPV, MPLC
57  2006 Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests. HPV, HPVs, MP, TNA
58  2005 The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies. EQA, HPV, IQC, LBC, PCR, QA